Skip to main content

Bifidobacterium infantis Disease Interactions

There is 1 disease interaction with bifidobacterium infantis.

Moderate

Probiotics (applies to bifidobacterium infantis) immunosuppression

Moderate Potential Hazard, Moderate plausibility. Applicable conditions: Immunodeficiency

Probiotics, especially those containing lactobacillus, should be used with caution in immunosuppressed patients.

References (3)
  1. "Product Information. Culturelle DS (lactobacillus rhamnosus GG)." ConAgra Functional Foods
  2. Salminen MK, Tynkkynen S, Rautelin H, et al. (2002) "Lactobacillus bacteremia during a rapid increase in probiotic use of Lactobacillus rhamnosus GG in Finland." Clin Infect Dis, 35, p. 1155-60
  3. Land MH, Rouster-Stevens K, Woods CR, Cannon ML, Cnota J, Shetty AK (2005) "Lactobacillus sepsis associated with probiotic therapy." Pediatrics, 115, p. 178-81

Switch to consumer interaction data

Bifidobacterium infantis drug interactions

There are 348 drug interactions with bifidobacterium infantis.

Report options

Loading...
QR code containing a link to this page

Drug Interaction Classification

These classifications are only a guideline. The relevance of a particular drug interaction to a specific individual is difficult to determine. Always consult your healthcare provider before starting or stopping any medication.
Major Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit.
Moderate Moderately clinically significant. Usually avoid combinations; use it only under special circumstances.
Minor Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan.
Unknown No interaction information available.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer